Brak pluginu Flash
NEWS  



  
01.06.10
CBDMT, The Market and Business Intelligence Company Reviews The Alzheimer\'s Disease Market

According to CBDMT, the market and business intelligence company, the Alzheimer's disease (AD) market was valued at $5.5 billion in 2009. The AD market is led by North America with a market share of 52% accounting for sales of $2.8 billion. The Alzheimer disease market could account for more than $10.1 billion by 2020.

Paris, France (PRWEB) June 1, 2010 -- Alzheimer's disease (AD) is by far the most common cause of dementia ... [ more ]

28.04.10
CBDM.T®, The Market and Business Intelligence Company Reviews The Dry Eye Disease Treatment Market

According to CBDM.T®, the market and business intelligence company, the Dry Eye market is huge and growing valued at 1.7 billion USD in 2009 with an annual growth of about 10 to 11%. The Dry Eye market could account for more than 2.4 billion USD by 2014.

Paris, France (PRWEB) April 28, 2010 -- Dry eye disease (DED) is one of the most frequently encountered ocular morbidities. 25 % percent of patients who ... [ more ]

29.01.10
CBDM.T et COMCLOVIS annoncent la création d’une « joint-venture »

Paris, le 29 janvier 2010 - COMCLOVIS, Agence Transversale en Stratégie, Création et Production, et CBDM.T, société de Market & Business Intelligence annoncent aujourd'hui la création d'un partenariat dans le domaine des sciences du vivant pour le compte des entreprises des industries pharmaceutiques, chimiques, cosmétiques et alimentaires.

L'intelligence économique est aujourd'hui un actif majeur de toute ... [ more ]

14.10.09
How the annual ILSI Biomed conference is turning Israel into the Life Science Industry\'s Promised land…

In June 2009, the eighth annual ILSI* (Israel Life Science Industry) Biomed conference was held in Tel Aviv. ILSI-Biomed is a young yet "fast growing" and keyed-up conference, and this year was the most successful and probably the most fruitful yet.

2000 visitors attended the first Biotech conference in Israel in 2002. Over the years the conference experienced a significant growth reaching more then 4000 participants in 2005, and in ... [ more ]

10.04.09
CBDM.T®, The Market and Business Intelligence Company Reviews The Vaccine Market

According to CBDM.T®, the market and business intelligence company, the vaccine market is a huge and growing market valued at €16 billion in 2008 with an annual growth of about 15 to 18%. The vaccine market could account for more than €25 billion by 2012.

Paris, France (PRWEB) April 10, 2009 -- Vaccines are ... [ more ]

27.11.08
CBDM.T®, the Market and Business Intelligence Company Reviews the Biofuel Market

According to CBDM.T®, the market and business intelligence company, the biofuel market is estimated at €33 billion with a double digit annual growth. The market consists of approximately 85% bioethanol and 15% biodiesel. Bioethanol is produced and consumed mainly in Brazil and North America. On the other hand, Europe is the world leader in biodiesel production and this fuel represents about ¾ of the European ... [ more ]

15.09.08
CBDM.T®, The Market and Business Intelligence Company Reviews The Biomanufacturing Market

According to CBDMT®, the market and business intelligence company, contract biomanufacturing is a significant market estimated at €2.3 billion this year with an annual growth of about 10 to 15%. Pharmaceutical biomanufacturing could account for more than 20% of the ... [ more ]

08.07.08
CBDM.T®, The Market and Business Intelligence Company Reviews The Enzyme Market

According to CBDM.T®, The market and business intelligence company, the enzyme market is significant and estimated at €3.4 billion with an annual growth of about 6.5 to 10%. Enzymes are sold in many different industry segments. These segments are Detergents, Food, ... [ more ]

26.05.08
CBDM.T®, the market and business intelligence company is pleased to announce the opening of a new office in Israel

To continue its growth in the life science industry, CBDM.T® is expanding its team with a new Israeli partner, Olivier Soussan. "The addition of Olivier to our team meets our customer's expectations to develop business in the very dynamic Life Science market in Israel" says Philippe Tramoy, managing partner.

Paris (PRWEB) May 26, 2008 -- CBDM.T®, the market and ... [ more ]

24.02.08
CBDMT Announces The Invisible Revolution: White Biotechnology

From the first recombinant protein in the 70s, modern biotechnology and more particularly the industrial or white biotechnology is a real alternative technology for the development and the production of goods from renewable resources (in 2015 up to €300 billion in chemical product sales will be bioproduced). It will allow increasing energy and processing efficiency (cost-effectiveness, flexibility, cleanness, sustainability). So please think not only about ... [ more ]

17.12.07
CBDMT® Announces the launch of lifescience-online.com

PARIS, December 17, 2007 -- CBDM.T® Ltd. (www.cbdmt.com) is pleased to announce the launch of Lifescience-online.com: the "Google of Pharma"(1) by its Swiss Partner LifeScience Consulting. Lifescience-online ([ more ]

29.05.06
CBDMT® Announces Collaboration Agreement with BioAdvice

PARIS, May 29, 2006 -- CBDM.T® Ltd. (www.cbdmt.com) today announced that it has entered into a strategic collaboration with BioAdvice Ltd. (www.bioadviceonline.com). Under the agreement, CBDM.T® and BioAdvice will not only identify but also audit some potential future partners or innovative ... [ more ]

15.05.06
LifeScience-Consulting and CBDMT® Enter Into a Joint Venture

PARIS, May 15, 2006 -- LifeScience-Consulting Inc. (www.lifescienceconsulting.com) is pleased to announce it has entered into a joint agreement with CBDM.T® Ltd.. This exciting collaboration will enable a broader range of services to be offered to business development departments, financial ... [ more ]

  2009 copyright by CBDMT
  designed by designum.pl